Treatment outcomes and patient-reported quality of life after orthognathic surgery with computer-assisted 2-or 3-dimensional planning: A randomized double-blind active-controlled clinical trial

被引:21
|
作者
Bengtsson, Martin [1 ]
Wall, Gert [1 ]
Larsson, Pernilla [2 ,3 ]
Becktor, Jonas P. [4 ]
Rasmusson, Lars [5 ]
机构
[1] Univ Hosp Skane, Dept Oral & Maxillofacial Surg, S-22185 Lund, Sweden
[2] Ostergotland Cty Council, Ctr Oral Rehabil, Linkoping, Sweden
[3] Malmo Univ, Fac Odontol, Dept Orofacial Pain & Jaw Funct, Malmo, Sweden
[4] Malmo Univ, Fac Odontol, Dept Oral & Maxillofacial Surg & Oral Med, Malmo, Sweden
[5] Gothenburg Univ, Sahlgrenska Acad, Dept Oral & Maxillofacial Surg, Gothenburg, Sweden
关键词
OROFACIAL AESTHETIC SCALE; CAD/CAM SURGICAL SPLINTS; DISTRACTION OSTEOGENESIS; PROSTHODONTIC PATIENTS; SWEDISH VERSION; ACCURACY; SIMULATION; IMPACT; RELIABILITY; VALIDITY;
D O I
10.1016/j.ajodo.2017.12.008
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Introduction: Thorough treatment planning is essential for a good clinical outcome in orthognathic treatment. The planning is often digital. Both 2-dimensional (2D) and 3-dimensional (3D) software options are available. The aim of this randomized 2-arm parallel double-blinded active-controlled clinical trial was to comprae the outcomes of computer-based 2D and 3D planning techniques according to patient-reported health related quality of life. The hypothesis was that a 3D technique would give a better treatment outcome compared with a 2D technique. Methods: Orthognathic treatment for 62 subjects, aged 18 to 28 years, with severe Class III malocclusion was planned with both 2D and 3D techniques. After treatment planning but before surgery, the patients were randomly allocated via blind collection of 1 enveloped card for each subject in a 1:1 ratio to the test (3D) or the control (2D) group. Thus, the intervention was according to which planning technique was used. The primary outcome was patient-reported outcome measures. The secondary outcome was relationship between patient-reported outcome measures and cephalometric accuracy. Questionnaires on the patient's health-related quality of life (HRQoL) were distributed preoperatively and 12 months after surgical treatment. The questionnaires were coded, meaning blinding throughout the analysis. Differences between groups were tested with the Fisher permutation test. The HRQoL was also compared with measurements of cephalometric accuracy for the 2 groups. Reslts: Three subjects were lost to clinical follow-up leaving 57 included. Of these, 55 subjects completed the questionnaires, 28 in the 2D and 27 in the 3D groups. No statistically significant difference regarding HRQoL was found between the studied planning techniques: the Oral Health Impact Profile total showed -3.69 (95% confidence interval, -19.68 to 12.30). Consistent results on HRQoL and cephalometric accuracy showed a difference between pretreatment and postreatment that increased in both groups but to a higher level in the 3D group. A difference between pretreatment and posttreatment HRQoL was shown for both groups, indicating increased quality of life after treatment. This supports recent findings comparing 3D and 2D planning techniques. No serious harm was observed during the study. Conclusions: Improvemens of HRQoL were shown after treatment independent of which planning technique, 2D or 3D, was used. No statisticaly significant difference was found between the planning techniqes. Registration: This trial was not registered. Protocol: The protocol was not published before trial commencement.
引用
收藏
页码:786 / 796
页数:11
相关论文
共 47 条
  • [1] PATIENT-REPORTED AND QUALITY OF LIFE OUTCOMES FROM MYCARING, A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL OF ROZANOLIXIZUMAB IN GENERALISED MYASTHENIA GRAVIS
    Habib, Ali A.
    Druzdz, Artur
    Grosskreutz, Julian
    Kaminski, Henry
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vissing, John
    Vu, Tuan
    Morel, Thomas
    Boehnlein, Marion
    Woltering, Franz
    Bozorg, Ali
    Gayfieva, Maryam
    Bril, Vera
    MUSCLE & NERVE, 2022, 65 : S19 - S20
  • [2] Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial
    Lipton, Richard B.
    Pozo-Rosich, Patricia
    Blumenfeld, Andrew M.
    Li, Ye
    Severt, Lawrence
    Stokes, Jonathan T.
    Creutz, Lela
    Gandhi, Pranav
    Dodick, David
    NEUROLOGY, 2023, 100 (08) : E764 - E777
  • [3] Patient-Reported Outcome Measures 2 Years After Standard and Distal Gastric Bypass—a Double-Blind Randomized Controlled Trial
    Marius Svanevik
    Hilde Risstad
    Tor-Ivar Karlsen
    Jon A. Kristinsson
    Milada Cvancarova Småstuen
    Ronette L Kolotkin
    Torgeir T Søvik
    Rune Sandbu
    Tom Mala
    Jøran Hjelmesæth
    Obesity Surgery, 2018, 28 : 606 - 614
  • [4] Patient-Reported Outcome Measures 2 Years After Standard and Distal Gastric Bypass-a Double-Blind Randomized Controlled Trial
    Svanevik, Marius
    Risstad, Hilde
    Karlsen, Tor-Ivar
    Kristinsson, Jon A.
    Smastuen, Milada Cvancarova
    Kolotkin, Ronette L.
    Sovik, Torgeir T.
    Sandbu, Rune
    Mala, Tom
    Hjelmesaeth, Joran
    OBESITY SURGERY, 2018, 28 (03) : 606 - 614
  • [5] Benefits of fibre retention osseous resective surgery in the treatment of shallow infrabony defects. A double-blind, randomized, clinical trial describing clinical, radiographic and patient-reported outcomes
    Cairo, Francesco
    Carnevale, Gianfranco
    Nieri, Michele
    Mervelt, Jana
    Cincinelli, Sandro
    Martinolli, Chiara
    Pini-Prato, Giovan Paolo
    Tonetti, Maurizio S.
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2013, 40 (02) : 163 - 171
  • [6] A comparative study of the analgesic effects of intravenous ketorolac, paracetamol, and morphine in patients undergoing video-assisted thoracoscopic surgery: A double-blind, active-controlled, randomized clinical trial
    Dastan, Farzaneh
    Langari, Zahra
    Salamzadeh, Jamshid
    Khalili, Ali
    Aqajani, Sahar
    Jahangirifard, Alireza
    ANNALS OF CARDIAC ANAESTHESIA, 2020, 23 (02) : 177 - 182
  • [7] Patient-Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Kavanaugh, Arthur
    McInnes, Iain B.
    Krueger, Gerald G.
    Gladman, Dafna
    Beutler, Anna
    Gathany, Tim
    Mack, Michael
    Tandon, Neeta
    Han, Chenglong
    Mease, Philip
    ARTHRITIS CARE & RESEARCH, 2013, 65 (10) : 1666 - 1673
  • [8] A 24-week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults
    Halvorsen, Yuan-Di
    Lock, John P.
    Zhou, Wenjiong
    Zhu, Fang
    Freeman, Mason W.
    DIABETES OBESITY & METABOLISM, 2019, 21 (10): : 2248 - 2256
  • [9] Patient-Reported Outcomes of Azelaic Acid Foam 15% for Patients With Papulopustular Rosacea: Secondary Efficacy Results From a Randomized, Controlled, Double-blind, Phase 3 Trial
    Tyring, Stephen
    Solomon, James A.
    Staedtler, Gerald
    Lott, Jason P.
    Nkulikiyinka, Richard
    Shakery, Kaweh
    CUTIS, 2016, 98 (04): : 269 - 275
  • [10] Patient-reported outcomes of multiple myeloma patients treated with panobinostat after ≥2 lines of therapy based on the international phase 3, randomized, double-blind, placebo-controlled PANORAMA-1 trial
    Richardson, Paul G.
    Schlossman, Robert L.
    Roy, Anuja N.
    Panneerselvam, Ashok
    Acharyya, Suddhasatta
    Sopala, Monika
    Lonial, Sagar
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (05) : 628 - 636